A patient may resist the move to insulin in the face of even irrefutable evidence that it's time. A GLP-1 RA is often moe attractive. Why? Also, why not?
TRIM-AGHD was found in this study to be highly responsive to patient-reported response to treatment in adults naïve to GH therapy.
The once-weekly novel growth hormone derivative was favored over once-daily hGH in this head-to-head trial that evaluated treatment satisfaction.
Can albiglutide reduce the risk of cardiovascular events in T2DM patients? A new study sheds some light.
A new study suggests it may be time to scrutinize the efficacy of the longstanding standard of care for hypothyroidism.
Three new studies in diabetes research highlight the importance of whole grains and gluten in T2DM and T1DM risk.
Tumor size does indeed matter in the recurrence rate of papillary thyroid carcinoma, according to a new study.
A new study has found that the link between subclinical hypothyroidism and metabolic syndrome is only present in type 2 diabetes.
Low serum estradiol found to have a causal effect on bone mineral density and fracture risk in men vs low testosterone, according to a new study.
Can weight loss alone be the key to the reversal of type 2 diabetes? A new study sheds some light.